Synthesis of a 188Re-HEDP complex using carrier-free 188Re, and a study of its stability

Applied Radiation and Isotopes

Volumn 49, Issue 4, 1998, Pages 351-356

  Hashimoto, Kazuyuki ^a  

^a JAPAN ATOMIC ENERGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; ETIDRONIC ACID; MEDRONIC ACID; REDUCING AGENT; RHENIUM 188; SODIUM CHLORIDE; STANNOUS CHLORIDE;

ARTICLE; COMPLEX FORMATION; DILUTION; GENERATOR; IONIC STRENGTH; PH; PRIORITY JOURNAL; REACTION TIME; SYNTHESIS; TEMPERATURE;

ANTIOXIDANTS; CARBOXYLIC ACIDS; COMPOSITION EFFECTS; IONIC STRENGTH; PH EFFECTS; RADIOISOTOPES; REDUCTION; RHENIUM COMPOUNDS; SYNTHESIS (CHEMICAL); THERMAL EFFECTS; TIN COMPOUNDS; VITAMINS;

ASCORBIC ACID; HYDROXYETHYLIDENEDIPHOSPHONIC ACID; STANNOUS CHLORIDE;

ORGANOMETALLICS;

EID: 0032034290     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8043(97)00284-4     Document Type: Article

References (27)

1. 186Re complex of 1-hycroxyethylidene-1,1-diphosphonate for treatment of painful osseous metastases. Radioisotopes 44, 514.
2. 186Re(Sn)-HEDP. J. Radioanal. Nucl. Chem., Art. 206, 43.
3. Callahan, A. P., Rice, D. E. and Knapp, F. F. Jr. (1989) Rhenium-188 for therapeutic applications from an alumina-based tungsten-188/rhenium-188 radionuclide generator. NucCompact 20, 3.
4. 99mTc. J. Nucl. Med. 15, 127.
5. 99mTc(Sn) EHDP complexes by HPLC and GPC. Appl. Radiat. Isot. 37, 23.
6. 99mTc-EHDP complexes. Appl. Radiat. Isot. 38, 611.
7. De Klerk, J. M. H., Van Dijk, A., Van het Schip, A. D., Zonnenberg, B. A. and Van Rijk, P. P. (1992) Pharmacokinetics of rhenium-186 after administration of rhenium-186-HEDP to patients with bone metastases. J. Nucl. Med. 33, 646.
8. De Klerk, J. M. H., Van het Schip, A. D., Zonnenberg, B. A., Van Dijk, A., Stokkel, M. P. M., Han, S. H., Blijham, G. H. and Van Rijk, P. P. (1994) Evaluation of thrombocyto-penia in patients treated with rhenium-186-HEDP: Guidelines for individual dosage recommendations. J. Nucl. Med. 35, 1423.
9. Deutsch, E., Libson, K., Vanderheyden, J.-L., Ketring, A. R. and Maxon H. R. (1986) The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine. Nucl. Med. Biol. 13, 465.
10. 186Re-perrhenate for nuclear medical purposes. Int. J. Appl. Radiat. Isot. 33, 99.
11. 188Re. Appl. Radiat. Isot. 47, 195.
12. 188Re generators. Appl. Radiat. Isot. 45, 1123.
13. Lewington, V. J. (1993) Targeted radionuclide therapy for bone matastases. Eur. J. Nucl. Med. 20, 66.
14. Mathieu, L., Chevalier, P., Galy, G. and Berger, M. (1979) Preparation of rhenium-186 labelled EHDP and its possible use in the treatment of osseous neoplasms. Int. J. Appl. Radiat. Isot. 30, 725.
15. Mausner, L. F. and Srivastava, S. C. (1993) Selection of radionuclides for radioimmunotherapy. Med. Phys. 20, 503.
16. Maxon, H. R., Deutsch, E. A., Thomas, S. R., Libson K., Lukes, S. J., Williams, C. C. and Ali S. (1988) Re-186(Sn)HEDP for treatment of multiple metastatic foci in bone: Human biodistribution and dosimetric studies. Radiology 166, 501.
17. Maxon, H. R. III, Schroder, L. E., Thomas, S. R., Hertzberg, V. S., Deutsch, E. A., Scher, H. I., Samaratunga, R. C., Libson, K. F., Williams, C. C., Moulton, J. S. and Schneider, H. J. (1990) Re-186(Sn) HEDP for treatment of painful osseous metastases: Initial clinical experience in 20 patients with hormone-resistant prostate cancer. Radiology 176, 155.
18. Maxon, H. R. III, Schroder, L. E., Hertzberg, V. S., Thomas, S. R., Englaro, E. E., Samaratunga, R., Smith H., Moulton, J. S., Williams, C. C., Ehrhardt, G. J. and Schneider, H. J. (1991) Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo. J. Nucl. Med. 32, 1877.
19. Mikelsons, M. V. and Pinkerton, T. C. (1986) Liquid chromatography of tin-reduced technetium hydroxyethylidene diphosphonate complexes for on-line spectral characterization and double isotope labeling. Anal. Chem. 58, 1007.
20. 2O. Gaodeng Xuexiao Huaxue Xuebao 6, 69; Chem. Abstr. 103, 204 074g.
21. 2O. Gaodeng Xuexiao Huaxue Xuebao 6, 69; Chem. Abstr. 103, 204 074g.
22. 4)-HEDP mixtures separated by anion exchange high performance liquid chromatography. Int. J. Appl. Radiat. Isot. 33, 907.
23. Quirijnen, J. M. S. P., Han, S. H., Zonnenberg, B. A., De Klerk, J. M. H., Van het Schip, A. D., Van Dijk, A., Ten Kroode, H. F. J., Blijham, G. H. and Van Rijk, P. P. (1996) Efficacy of rhenium-186-etidronate in prostate cancer patients with metastatic bone pain. J. Nucl. Med. 37, 1511.
24. 4)-MDP radiopharmaceutical analogues. Int. J. Appl. Radiat. Isot. 34, 1577.
25. Tanabe, S., Zodda, J. P., Libson, K., Deutsch, E. and Heineman, W. R. (1983b) The biological distributions of some technetium-MDP components isolated by anion exchange high performance liquid chromatography. Int. J. Appl. Radiat. Isot. 34, 1585.
26. Vera-Ruiz, H. (1993) Radiopharmaceuticals as therapeutic agents in medical care and treatment. IAEA Bull. 35, 24.
27. 4)-HEDP components separated by anion exchange HPLC. Appl. Radiat. Isot. 37, 345.